Pacemakers have saved a lot of lives over the years by helping to regulate the heartbeats of those with arrhythmia. The problem, however, is that those pacemakers run on batteries that have a tendency to run out of juice after a while. As a result, patients have to undergo an invasive procedure every once in a while in order to stay alive. By utilizing the technology that allows wristwatches to function, this problem may have finally been addressed.
The researchers responsible for the discovery are Andreas Haeberlin and Adrian Zurbuchen from the University of Bern and the University of Michigan, Futurism reports. The method that the pair proposed basically involves initiating a cycle between the pacemaker and the heart, where the heartbeat will give the pacemaker power via kinetic energy and the pacemaker will give the heart assistance in order to maintain a consistent rhythm.
By setting the system up like this, it creates a loop where the pacemaker is continuously powered and the heartbeat is continuously maintained to have a normal pace. Basically, the researchers just made the heart the battery for the thing that’s keeping it working. A symbiotic relationship, in a sense.
Aside from pacemakers, this discovery could potentially also have an impact on other implanted devices, TechXplore reports. These could include defibrillators or electrical stimulators that keep important organs from ceasing to function. This is a solution that addresses one of the biggest problems involved in implanted devices.
"Repeated battery replacement procedures can be avoided by extending the implants lifespan, which is the goal of energy harvesting concepts,” the Abstract of the paper reads. This reduces the risk of complications for the patient and may even reduce device size. The continuous and powerful contractions of a human heart ideally qualify as a battery substitute."


Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation
AI-Guided Drones Transform Ukraine’s Battlefield Strategy
Nexperia Urges China Division to Resume Chip Production as Supply Risks Mount
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup
Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Australia Releases New National AI Plan, Opts for Existing Laws to Manage Risks
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
TSMC Accuses Former Executive of Leaking Trade Secrets as Taiwan Prosecutors Launch Investigation 



